Daniel F. Hayes

发表

John B. Anderson, A Campbell, C Gunter, 2015 .

Integrative Clinical Genomics of Metastatic Cancer

Robert J. Lonigro, Daniel F. Hayes, Arul M. Chinnaiyan, 2017, Nature.

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Debashis Ghosh, Ronglai Shen, Daniel F. Hayes, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

Daniel F. Hayes, D. Hayes, N. Tokudome, 2013 .

The NCCN. Invasive breast cancer: Clinical practice guidelines in oncology™

Lawrence B. Marks, Robert W. Carlson, Daniel F. Hayes, 2007 .

Women’s interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid

Sarah M. Greene, Angela Fagerlin, Jennifer B. McClure, 2011, Breast Cancer Research and Treatment.

Indications for Prognostic Gene Expression Profiling in Early Breast Cancer

Daniel F. Hayes, Erin F. Cobain, D. Hayes, 2015, Current Treatment Options in Oncology.

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer

Todd C. Skaar, David A. Flockhart, Daniel F. Hayes, 2016, The oncologist.

Is There a Role for Circulating Tumor Cells in the Management of Breast Cancer?

Daniel F. Hayes, D. Hayes, J. Smerage, 2008, Clinical Cancer Research.

ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients

Daniel F. Hayes, Arul M. Chinnaiyan, Heather A. Parsons, 2015, Clinical Cancer Research.

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

David A. Flockhart, Daniel F. Hayes, Richard M. Weinshilboum, 2005, Journal of the National Cancer Institute.

Biomarkers in Breast Cancer

Daniel F. Hayes, Giampietro Gasparini, D. Hayes, 2006 .

Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?

Daniel F. Hayes, Adrian L. Harris, B. Trock, 2004, Breast Cancer Research and Treatment.

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.

Thomas J. Smith, Robert C. Bast, Daniel F. Hayes, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract P1-01-01: Analytical validation of a standardized scoring protocol for Ki67: Phase-3 of an international multicenter collaboration

Daniel F. Hayes, Lisa M. McShane, Indu Arun, 2016 .

20‐Year Risks of Breast‐Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

Daniel F. Hayes, Mitch Dowsett, Jonas Bergh, 2017, The New England journal of medicine.

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

Norah Lynn Henry, Steffi Oesterreich, Todd C. Skaar, 2009, The Pharmacogenomics Journal.

Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer

Zhe Zhang, David A. Flockhart, Daniel F. Hayes, 2012, Breast Cancer Research and Treatment.

ESR 1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients

Daniel F. Hayes, Arul M. Chinnaiyan, Heather Parsons, 2015 .

Prechemotherapy alterations in brain function in women with breast cancer

Douglas C. Noll, Daniel Normolle, Marc G. Berman, 2010, Journal of clinical and experimental neuropsychology.

Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer

Steffi Oesterreich, Todd C. Skaar, David A. Flockhart, 2013, Breast Cancer Research and Treatment.

Women’s decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid

Sarah M. Greene, Angela Fagerlin, Jennifer B. McClure, 2010, Breast Cancer Research and Treatment.

Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

Leon W.M.M. Terstappen, Daniel F. Hayes, Massimo Cristofanilli, 2006, Clinical Cancer Research.

Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer-Clinical Notice

Anthony Rhodes, Paul Valenstein, Daniel F. Hayes, 2010 .

Sensitive capture of circulating tumour cells by functionalised graphene oxide nanosheets

Daniel F. Hayes, Hyeun Joong Yoon, Nithya Ramnath, 2013, Nature nanotechnology.

Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy

Mark A. Helvie, Marilyn A. Roubidoux, Chintana Paramagul, 2005, Breast Cancer Research and Treatment.